Dental Implantology for Head and Neck Cancer Patients

Collaboration Between Dentists & Radiation Oncologists

CE Credits: 1.0 | Credit Type: Online, self-instruction | AGD Code: 310

Duration: 1 hour | Start Time: On-Demand

Presented by Ryan S. Lee, DMD and Jared Robbins, MD

On-Demand CE Webinar

Originally Aired On

August 6th, 2025

Register now for free webinar and recording access below:

ABOUT THE WEBINAR

Can dental implants be performed safely in cancer patients and survivors? Dentistry for head & neck cancer patients (pre- or post-radiation therapy) involves close collaboration between dentists and oncologists. Oral complication risks (e.g., osteonecrosis, mucositis, implant failure) warrant certain considerations for both surgical and prosthetic implant therapy.

This lecture is a primer on strategies for dentists to communicate with oncologists to deliver timely and safe implant care for cancer patients before and after radiation.

Learning Objectives:

✅Understanding oral complications associated with head & neck radiation for cancer

✅The specific metrics that dentists should obtain from radiation oncologists

✅How to provide safe and effective dental implantology in the irradiated jaw

About the Speakers

Ryan S. Lee, DDS, MPH, MHA, FICOI, FAGD

Dr. Ryan Lee completed a postgraduate Fellowship in Dental Oncology, Department of Surgery, Memorial Sloan Kettering Cancer Center in 2013. Prior to that, he obtained his DDS from NYU College of Dentistry, with honors, in 2010. Over the past 15 years, Dr. Lee has maintained a practice focused on oral oncology and dental implantology, in both private practice and academic settings. Currently, he serves as Founder of New York Center for Dental Oncology and Linkstone Implant Academy. Since 2009, Dr. Lee has also served as a reserve officer, currently holding the rank of Lieutenant Colonel, Comprehensive Dental Officer, with the US Army Reserve.

Jared Robbins, MD

Dr. Jared Robbins is an Instructor in Radiation Oncology at Duke University, specializing in head and neck cancers. He completed his medical degree at the University of Arizona and residency at Henry Ford Health System. Dr. Robbins is dedicated to patient care, education, and research. His current NCI-funded study (2024–2029) explores computational tumor phenotyping to better understand treatment resistance. He has published extensively on imaging, precision radiotherapy, and outcomes in aggressive thyroid cancers.

Spark Study Club

Nationally Approved PACE Program Provider

for FAGD/MAGD credit.

Approval does not imply acceptance by any

regulatory authority or AGD endorsement.

4/1/2025 to 3/31/2027.

Provider ID# 434246

Copyright 2025. All Right are Reserved. Spark Study Club